title: Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics.
abstract: BACKGROUND
  Obesity and type 2 diabetes are associated with renal dysfunction, which improves after Roux-en-Y gastric bypass (RYGB). During a 12-month follow-up period, we studied prospectively the changes in glomerular and tubular functions that occurred in excessively obese diabetic and non diabetic subjects after RYGB.
  
  
  METHODS
  The cohort included 35 patients, 54% of whom had type 2 diabetes. Glomerular filtration rate (GFR) was estimated using creatinine clearance. Tubular function was studied by measuring the ratio of urinary cystatin C to urinary creatinine (UCC ratio).
  
  
  RESULTS
  Baseline renal parameters, anthropometric characteristics, and changes in body mass index after the surgical procedures were similar between the 2 cohorts. At 12 months after RYGB, creatinine clearance decreased 15% in diabetics (P = .02) and 21% in nondiabetics (P = .03). A change in GFR was seen earlier in the nondiabetics (-29% after 6 months; P = .003). The UCC ratio was increased at both 6- and 12-month follow-ups (P = .03 and .003, respectively) only in the diabetic group.
  
  
  CONCLUSIONS
  GFR was improved at 12 months after RYGB, with nondiabetics showing a greater propensity score. Tubular function remained unchanged in the nondiabetic subjects, but worsening occurred in the diabetic subjects. These results underscore the importance of reversal of excessive obesity before the onset of frank diabetes.
authors.affiliation: Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN, USA.
authors.forename: Jabbar
authors.initials: J
authors.lastname: Saliba
authors.forename: Nader R
authors.initials: NR
authors.lastname: Kasim
authors.forename: Robyn A
authors.initials: RA
authors.lastname: Tamboli
authors.forename: James M
authors.initials: JM
authors.lastname: Isbell
authors.forename: Pam
authors.initials: P
authors.lastname: Marks
authors.forename: Irene D
authors.initials: ID
authors.lastname: Feurer
authors.forename: Alp
authors.initials: A
authors.lastname: Ikizler
authors.forename: Naji N
authors.initials: NN
authors.lastname: Abumrad
mesh_terms: D000328:Adult; D015992:Body Mass Index; D003404:Creatinine / Q000378:metabolism; D055316:Cystatin C / Q000652:urine; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology; D005260:Female; D015390:Gastric Bypass; D005919:Glomerular Filtration Rate; D006801:Humans; D007677:Kidney Function Tests; D007678:Kidney Glomerulus / Q000503:physiopathology; D007684:Kidney Tubules / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000150:complications / Q000503:physiopathology / Q000601:surgery*
chemical_list: D055316:Cystatin C; D003404:Creatinine